speb/financial-data huggingface dataset:
Financial scorecard for AMPL (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 8.05
Market cap: 1074215936 (USD: 1074215936)
P/B ratio: 3.2598123675018984
Debt to equity: 0.0467
Current ratio: 1.52
Return on net tangible assets (%): -11.369359004970804
Buffett classification: The Gruesome
Analyst consensus upside (%): 66.56891495601171
Rule of 40 score: -33.187132100279605
Altman Z-score: 1.8110292849263034 (Grey Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.9295934183571821
Debt paydown yield (%): -0.05399286871126813
Total shareholder yield (%): 1.875600549645914 (Low Return)
Momentum (%): 1m 17.862371888726216, 3m 14.02266288951843, 6m -21.463414634146336, 12m -36.614173228346445, composite -17.887074728524258 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 16.93369854789688
Revenue deceleration: no
Accrual ratio: -0.02455175298446304
FCF conversion rate: 0.5662112228237518
Beneish M-score: -2.0513445139458715 (Likely Safe)
ROE (%): -10.06114760370128
Net margin (%): -24.89410858683096
Asset turnover: 0.2273566253985161
Equity multiplier (leverage): 1.7776380035923407
ROE archetype: Low Return
FCF z-score: 3.7779353284591815
Treasury beta 1y: 0.021437997938814925 (R-squared: 0.021983699028342702)
Insider 90-day net shares: -70026 (net value USD: -554518.00)
ROIC (%): -120.55370114284807 (pretax: -152.59962169980767)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 45.28301886792453, ROIC 73.31536388140162, revenue growth 1y 22.237196765498652, 6m momentum 53.09973045822103
Sector percentiles: P/E , 6m momentum 56.22288955622289
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.126067569597583
Base cash flow: -80557000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AMRX (Healthcare — Drug Manufacturers - Specialty & Generic, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 17.92
Market cap: 5722418176 (USD: 5722418176)
P/E ratio: 33.5945945945946
Debt to equity: 67.5084
Current ratio: 2.47
Interest coverage ratio: 2.7786023500309214
Return on net tangible assets (%): -9.14171095666394
Buffett classification: The Great
Analyst consensus upside (%): 50.84473049074819
Rule of 40 score: -19.199520140703747
Altman Z-score: 1.4753971168753037 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 9.103965320332552, earnings yield % 1.7867798223461833, rank 463
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.13003244032754868
Total shareholder yield (%): -0.13003244032754868 (Minimal or Negative)
Momentum (%): 1m 3.763752171395496, 3m 43.13099041533548, 6m 33.83121732636297, 12m 124.00000000000003, composite 64.27906924723281 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 0, short score 8, recommendation: Short
Revenue growth 1y (%): 3.8967818009260524
Net income growth 1y (%): 216.84133560809164
Revenue deceleration: no
Accrual ratio: 0.03503582047123931
FCF conversion rate: -0.6211923076923077
Beneish M-score: -2.35534357771443 (Likely Safe)
Net margin (%): 10.795563853684124
Asset turnover: 0.20018541253318903
ROE archetype: Standard Business
P/E z-score: 1.7732242264270717
FCF z-score: 4.229026840252378
Treasury beta 1y: -0.002558046906397279 (R-squared: 0.0011678721020192202)
Insider 90-day net shares: -34819 (net value USD: -450558.00)
ROIC (%): 15.656318954163096 (pretax: 17.036265117601324)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 50.146627565982406, P/B , ROIC 17.302052785923756, revenue growth 1y 36.36363636363637, 6m momentum 11.730205278592376
Sector percentiles: P/E 28.832378223495702, 6m momentum 9.563037249283667
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10265765346957223
Base cash flow: 254756000
DCF price per share: base 11.871177940142427, conservative 5.060313291773225, aggressive 22.714062154632735
Financial scorecard for APEI (Consumer Defensive — Education & Training Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 47.71
Market cap: 875167808 (USD: 875167808)
P/E ratio: 29.471502590673577
P/B ratio: 3.407893121160159
Debt to equity: 0.5012
Current ratio: 2.98
Interest coverage ratio: 30.064827586206896
Return on net tangible assets (%): 10.0228531126489
Buffett classification: The Great
Analyst consensus upside (%): 9.300281293952178
Rule of 40 score: 43.81324508799281
Altman Z-score: 3.1434672880712444 (Safe Zone)
Piotroski F-score: 8 (Strong)
Magic formula: return on capital % 7.001567539092113, earnings yield % 2.6875772846466037, rank 414
Dividend yield (%): 0
Buyback yield (%): 0.9952377041729579
Debt paydown yield (%): 1.0857346343342649
Total shareholder yield (%): 2.0809723385072227 (Low Return)
Momentum (%): 1m -8.478802992518707, 3m -14.267744833782567, 6m 9.25120219830547, 12m 60.74797843665769, composite 23.541206363196768 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): 6.190785835394497
Net income growth 1y (%): 99.38153603958169
Revenue deceleration: no
Accrual ratio: -0.08127008341105527
FCF conversion rate: 3.427725452597146
Beneish M-score: -3.1906799284212504 (Likely Safe)
ROE (%): 5.901019557465134
Net margin (%): 10.147191795717015
Asset turnover: 0.3299022402797234
Equity multiplier (leverage): 1.762771092958281
ROE archetype: Standard Business
P/E z-score: 2.5536562849496014
FCF z-score: 4.020258521047813
Treasury beta 1y: 8.396013693999872e-05 (R-squared: 6.751573309076753e-07)
Insider 90-day net shares: -14500 (net value USD: -762189.00)
ROIC (%): 13.710482530406646 (pretax: 18.988390499458834)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 56.25, P/B 56.25, ROIC 24.431818181818183, revenue growth 1y 20.454545454545457, 6m momentum 13.068181818181818
Sector percentiles: P/E 57.13251267197683, 6m momentum 18.464880521361334
Industry median P/E: 0.7407447752031963; industry median ROIC: 7.725919109881382
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.1025527633488195
Base cash flow: 24746000
DCF price per share: base 18.164774854729338, conservative 16.295829759534573, aggressive 20.366460211312138
Financial scorecard for APGE (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 134.28
Market cap: 10155169792 (USD: 10155169792)
P/B ratio: 4.164969229092693
Debt to equity: 0.0064
Current ratio: 32.59
Return on net tangible assets (%): -5.869040518620505
Buffett classification: The Gruesome
Analyst consensus upside (%): 55.07900677200903
Rule of 40 score: 0
Altman Z-score: 160.9996704344641 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.007897455349607216
Total shareholder yield (%): 0.007897455349607216 (Low Return)
Momentum (%): 1m 1.1982817092471199, 3m 56.850835182805746, 6m 91.77377892030849, 12m 222.47838616714697, composite 122.4281854887422 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.016622825656225512
FCF conversion rate: 0.7498212141247588
Beneish M-score: -2.6026531484229425 (Likely Safe)
ROE (%): -6.863159103495153
Asset turnover: 0
Equity multiplier (leverage): 1.0329271612964166
ROE archetype: Low Return
Treasury beta 1y: -0.00709595392535583 (R-squared: 0.0019366665904935942)
Insider 90-day net shares: -186900 (net value USD: -22055612.00)
ROIC (%): -123.60033417333187 (pretax: -156.4561192067492)
Incremental ROIC 3y (%): -104.67402458995087 (pretax: -132.49876530373527)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 41.7870036101083, ROIC 27.075812274368232, revenue growth 1y , 6m momentum 3.6101083032490973
Sector percentiles: P/E , 6m momentum 2.614613180515759
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06502702817917448
Base cash flow: -259572000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for API (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 3.85
Market cap: 325516672 (USD: 325516672)
P/E ratio: 39.333333333333336
P/B ratio: 0.41813686147154927
Debt to equity: 0.1671
Current ratio: 6.7
Interest coverage ratio: -109.8
Return on net tangible assets (%): -1.6637276700145673
Buffett classification: The Gruesome
Analyst consensus upside (%): 63.84180790960451
Rule of 40 score: -18.67844719085984
Altman Z-score: 0.8173021814181296 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 4.087041047163323
Debt paydown yield (%): -3.174338179520341
Total shareholder yield (%): 0.9127028676429823 (Low Return)
Momentum (%): 1m -6.553398058252427, 3m 6.944444444444445, 6m -16.84665226781857, 12m -4.466501240694793, composite -2.556319067675578 (Flat)
Lynch category: Asset Play (confidence: High)
Screener: long score 3, short score 14, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 13.453966154678533
Net income growth 1y (%): 172.48157248157247
Revenue deceleration: no
Revenue growth consistency score: 5.096327830536981
Accrual ratio: 0.006683821346852273
FCF conversion rate: -3.3552750225428314
Beneish M-score: -2.950738513355056 (Likely Safe)
ROE (%): 0.19849295699020958
Net margin (%): 2.9381375016558486
Asset turnover: 0.05223205729543252
Equity multiplier (leverage): 1.2934089241287967
ROE archetype: Low Return
P/E z-score: 1.3308931609618615
Treasury beta 1y: 0.012721860964597686 (R-squared: 0.011589737124613461)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -2.138238231140006 (pretax: -2.21048205422141)
Incremental ROIC 3y (%): 59.34042532281294 (pretax: 76.8333075627243)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 49.32614555256065, P/B 7.951482479784366, ROIC 50.943396226415096, revenue growth 1y 26.1455525606469, 6m momentum 46.495956873315365
Sector percentiles: P/E 46.81348014681348, 6m momentum 51.217884551217885
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.06870980450835029
Base cash flow: -14349000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ARRY (Technology — Solar, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 5.32
Market cap: 818356416 (USD: 818356416)
P/E ratio: 139.2294332674011
P/B ratio: 4.151665321333114
Debt to equity: 2.8489999999999998
Current ratio: 2.25
Interest coverage ratio: 0.8130505123134999
Return on net tangible assets (%): -10.683223077757294
Buffett classification: The Gruesome
Analyst consensus upside (%): 35.822959889349924
Rule of 40 score: -19.459274187582736
Altman Z-score: 0.5667203639762506 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 0.7004985418541296, earnings yield % 0.24276412410369103, rank 2717
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.3649998877750596
Total shareholder yield (%): 0.3649998877750596 (Low Return)
Momentum (%): 1m -30.819245773732117, 3m -34.401972872996296, 6m -49.47768281101614, 12m -20.35928143712574, composite -22.919965068323503 (Moderate Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 0, short score 12, recommendation: Short
Revenue growth 1y (%): -26.11132975926287
Net income growth 1y (%): -88.07476412277559
Revenue deceleration: no
Accrual ratio: 0.02660157666053145
FCF conversion rate: -18.493740610916376
Beneish M-score: -2.6411721213184967 (Likely Safe)
ROE (%): 0.7560499136808311
Net margin (%): 0.8938642508012103
Asset turnover: 0.1526654022677863
Equity multiplier (leverage): 5.540363676287972
ROE archetype: Low Return
FCF z-score: 3.1531460524316213
Treasury beta 1y: 0.0010870130815198806 (R-squared: 3.3106460895100796e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 7.447801245984047 (pretax: 9.427596513903858)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 50, P/B 43.05555555555556, ROIC 26.38888888888889, revenue growth 1y 52.77777777777778, 6m momentum 66.66666666666666
Sector percentiles: P/E 53.38672005338672, 6m momentum 77.74441107774442
Industry median P/E: 2.8170500105507488; industry median ROIC: 0.4760017097045983
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10496745120127872
Base cash flow: -26919000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ART.AX (Communication Services — Internet Content & Information, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.1527777777777778
Market cap: 107627960 (USD: 70345071.89542483)
Current ratio: 3.33
Buffett classification: The Gruesome
Analyst consensus upside (%): 123.61538461538461
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 5.489417989417989, 3m -14.444444444444441, 6m -25.648148148148138, 12m -17.60912698412698, composite -20.663048105576834 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 0, short score 3, recommendation: Neutral
Revenue deceleration: no
Revenue growth consistency score: 15.8161580143538
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.00348176267720003 (R-squared: 0.00061975537800731)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 57.438016528925615
Sector percentiles: P/E , 6m momentum 62.73393002441009
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.10850000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ART.L (Consumer Defensive — Beverages - Wineries & Distilleries, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0030666666666666668
Market cap: 15931058 (USD: 21528456.756756756)
P/B ratio: 0.03146053235755357
Debt to equity: 4.793
Current ratio: 3.3
Interest coverage ratio: -1.8958333333333335
Return on net tangible assets (%): -117.84982299236071
Buffett classification: The Gruesome
Analyst consensus upside (%): 1632252.9411764704
Rule of 40 score: -35.62905965760398
Altman Z-score: 0.740366155536113 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.067470114123613
Total shareholder yield (%): 2.067470114123613 (Low Return)
Momentum (%): 1m -19.63218390804597, 3m -21.747126436781606, 6m -33.25490196078432, 12m -49.570370370370384, composite -30.75116346195668 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 4, recommendation: Neutral
Revenue growth 1y (%): -9.000649308263398
Revenue CAGR 3y (%): 0.7611223303622516
Revenue deceleration: yes
Revenue growth consistency score: 11.311518653790383
Accrual ratio: -0.041089660228650224
FCF conversion rate: 0.7253035320088301
Beneish M-score: -2.8720867272189494 (Likely Safe)
ROE (%): -67.17704413591116
Net margin (%): -36.48444578677137
Asset turnover: 0.4099885434969189
Equity multiplier (leverage): 4.490983048176914
ROE archetype: Low Return
Treasury beta 1y: 0.016706808600902557 (R-squared: 0.04110305003114276)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -40.494698475811774 (pretax: -51.25911199469845)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 6.666666666666667, ROIC 88.33333333333333, revenue growth 1y 41.66666666666667, 6m momentum 75
Sector percentiles: P/E , 6m momentum 72.2664735698769
Industry median P/E: 8.540172771804777; industry median ROIC: 4.851856938633267
Sector median P/E: 1.0302878025850322; sector median ROIC: 7.163828537874342
WACC: 0.15
Base cash flow: -8547297.297297297
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ARTG.V (Basic Materials — Other Precious Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 24.092198581560286
Market cap: 7917237248 (USD: 5695854135.251799)
P/E ratio: 13.99910999035823
P/B ratio: 7.774494477669441
Debt to equity: 0.5221
Current ratio: 0.87
Interest coverage ratio: 15.240686449767608
Return on net tangible assets (%): 2.782858728366196
Buffett classification: The Good
Analyst consensus upside (%): 92.5380132450331
Rule of 40 score: 1.7965435049510576
Altman Z-score: 3.7281618754454176 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 10.084349696392191, earnings yield % 1.8403498447359965, rank 389
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.24144030121975624
Total shareholder yield (%): 0.24144030121975624 (Low Return)
Momentum (%): 1m 12.981908803882448, 3m -11.912698007105432, 6m -26.638936358002663, 12m 24.53588016313946, composite -9.441747904698145 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 7, short score 2, recommendation: Neutral
Revenue growth 1y (%): 690.0717602556132
Net income growth 1y (%): 2430.942070987759
Revenue deceleration: no
Accrual ratio: 0.03191358314911555
FCF conversion rate: 0.2811646234676007
Beneish M-score: -2.3545687541234592 (Likely Safe)
ROE (%): 10.581653981152522
Net margin (%): 36.20994156311532
Asset turnover: 0.12260785706493416
Equity multiplier (leverage): 2.383457598081756
ROE archetype: Standard Business
P/E z-score: 1.7213726044965545
FCF z-score: 1.7213726044965543
Treasury beta 1y: -0.0029673833337898934 (R-squared: 0.0005944367488699261)
Insider 90-day net shares: -769189 (net value USD: -21795469.00)
ROIC (%): 29.55732285110107 (pretax: 45.16536634003687)
Incremental ROIC 3y (%): 41.48271188744384 (pretax: 63.12597053232454)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 12.034383954154727, P/B 48.13753581661891, ROIC 1.146131805157593, revenue growth 1y 0, 6m momentum 36.67621776504298
Sector percentiles: P/E 27.679067184897278, 6m momentum 51.77679067184897
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12832917108176928
Base cash flow: -13960583.941605866
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ATC.L (Communication Services — Entertainment, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0244
Market cap: 43458252 (USD: 58727367.56756757)
P/B ratio: 0.027938551323328793
Debt to equity: 0.7663
Current ratio: 1.25
Interest coverage ratio: -0.8956834532374102
Return on net tangible assets (%): -1070.2857142857142
Buffett classification: The Gruesome
Rule of 40 score: 48.04812035741367
Altman Z-score: 1.808238388191019 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.035335439592834174
Total shareholder yield (%): -0.035335439592834174 (Minimal or Negative)
Momentum (%): 1m 10.380952380952396, 3m 10.773006134969346, 6m 35.75939849624061, 12m , composite 23.26620231560498 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 3, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.163909994647784
FCF conversion rate: -1.0031675641431739
Beneish M-score: -1.8547314331875624 (Likely Safe)
Equity multiplier (leverage): 5.901991597358539
ROE archetype: Standard Business
FCF z-score: 1.6988862142132581
Treasury beta 1y: 8.579293002763589e-05 (R-squared: 3.7103963733632623e-06)
Insider 90-day net shares: 548000 (net value USD: 916256.00)
ROIC (%): -69.1423550087877 (pretax: -87.52196836555405)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 3.30188679245283, ROIC 74.52830188679245, revenue growth 1y , 6m momentum 7.547169811320755
Sector percentiles: P/E , 6m momentum 6.509357200976404
Industry median P/E: 3.7313797891504157; industry median ROIC: 1.542068936425999
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.06498393476292694
Base cash flow: -2531081.0810810807
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AUPH (Healthcare — Biotechnology, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 15.35
Market cap: 1974035712 (USD: 1974035712)
P/E ratio: 6.861111111111111
P/B ratio: 4.667102462300529
Debt to equity: 0.1209
Current ratio: 5.55
Interest coverage ratio: 40.930830039525695
Return on net tangible assets (%): 6.937855030529966
Buffett classification: The Great
Analyst consensus upside (%): 14.709851551956813
Rule of 40 score: 42.28286865522354
Altman Z-score: 10.287857951421625 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 8.872828222028485, earnings yield % 1.79070215522662, rank 477
Dividend yield (%): 0
Buyback yield (%): 1.3180098745605062
Debt paydown yield (%): 0.26473707006797076
Total shareholder yield (%): 1.582746944628477 (Low Return)
Momentum (%): 1m -17.561761546723957, 3m -3.9424280350438092, 6m 5.6434962147281515, 12m 69.23925027563395, composite 35.66441339175807 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): 27.977451545527376
Net income growth 1y (%): 51.40350022928881
Revenue deceleration: no
Accrual ratio: 0.002467448128354596
FCF conversion rate: 0.9466162130694222
Beneish M-score: -2.2389513719301166 (Likely Safe)
ROE (%): 5.936358450060446
Net margin (%): 44.21208416446818
Asset turnover: 0.10454365147971321
Equity multiplier (leverage): 1.2843443029251773
ROE archetype: Standard Business
P/E z-score: 2.7320913253817074
FCF z-score: 2.732091325381707
Treasury beta 1y: -0.0020449428869416665 (R-squared: 0.00042352490427968276)
Insider 90-day net shares: 1091669 (net value USD: 16688909.00)
ROIC (%): 32.61068929985356 (pretax: 41.27935354411843)
Incremental ROIC 3y (%): 73.93743101573236 (pretax: 93.59168483004096)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 7.310469314079422, P/B 44.314079422382676, ROIC 2.527075812274368, revenue growth 1y 11.552346570397113, 6m momentum 23.375451263537904
Sector percentiles: P/E 18.624641833810887, 6m momentum 22.95845272206304
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.12348885380510105
Base cash flow: 223648905.10948905
DCF price per share: base 44.50304957468361, conservative 27.470969687347978, aggressive 73.65338038996197
Financial scorecard for AURA (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 7.05
Market cap: 729226752 (USD: 729226752)
P/B ratio: 6.452298181207866
Debt to equity: 0.15839999999999999
Current ratio: 7.09
Return on net tangible assets (%): -31.248426529413408
Buffett classification: The Gruesome
Analyst consensus upside (%): 181.01644245142
Rule of 40 score: 0
Altman Z-score: 9.202238833318763 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.05293278105079722
Total shareholder yield (%): 0.05293278105079722 (Low Return)
Momentum (%): 1m 0.1420454545454515, 3m -3.026134800550203, 6m 24.11971830985916, 12m -0.141643059490082, composite 6.936765796776264 (Moderate Downtrend)
Lynch category: Turnaround (confidence: Medium)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.02403071242270609
FCF conversion rate: 0.8904556924447083
Beneish M-score: -2.5912298390948414 (Likely Safe)
ROE (%): -27.5925622542595
Asset turnover: 0
Equity multiplier (leverage): 1.2578104521625164
ROE archetype: Low Return
Treasury beta 1y: -0.0008040187450892059 (R-squared: 3.802024927902578e-05)
Insider 90-day net shares: -6947432 (net value USD: -56932265.00)
ROIC (%): -886.7040501542442 (pretax: -1122.4101900686635)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 52.075812274368225, ROIC 41.15523465703971, revenue growth 1y , 6m momentum 14.530685920577618
Sector percentiles: P/E , 6m momentum 12.750716332378223
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06842008114061675
Base cash flow: -105509000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AURR.L (Consumer Cyclical — Auto Parts, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0092
Market cap: 61219020 (USD: 82728405.4054054)
P/B ratio: 0.03522087905993175
Debt to equity: 0.0036
Current ratio: 7.27
Interest coverage ratio: -123.03030303030303
Return on net tangible assets (%): -22.178787431774595
Buffett classification: The Gruesome
Analyst consensus upside (%): 1579168.2926829269
Rule of 40 score: -90.7303371129458
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.5977862829388465
Total shareholder yield (%): 0.5977862829388465 (Low Return)
Momentum (%): 1m 1.3333333333333304, 3m -12.717948717948731, 6m -17.975903614457835, 12m -9.226666666666674, composite -13.704968321328506 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.1527123377175244
FCF conversion rate: 1.8122595537317263
Beneish M-score: -1.1219496048431465 (Strong Manipulation Signal)
ROE (%): -26.125747329381078
Net margin (%): -48.7375
Asset turnover: 0.38575898381439694
Equity multiplier (leverage): 1.389598783166013
ROE archetype: Low Return
Treasury beta 1y: 0.0005794331025563368 (R-squared: 2.2018514822371266e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -34.01633259094283 (pretax: -43.05864884929473)
Incremental ROIC 3y (%): -23.388266766086733 (pretax: -29.605400969730045)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 1.6528925619834711, ROIC 90.08264462809917, revenue growth 1y , 6m momentum 69.6969696969697
Sector percentiles: P/E , 6m momentum 63.24756606397774
Industry median P/E: 0.2842479295922772; industry median ROIC: 7.591641841963527
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.06332063963673569
Base cash flow: -4063513.5135135134
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AUXX.V (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.7659574468085107
Market cap: 655193408 (USD: 471362164.028777)
P/B ratio: 5.602405893165003
Debt to equity: 0.0009
Current ratio: 5.49
Interest coverage ratio: -591.7804404145078
Return on net tangible assets (%): -8.097610175616673
Buffett classification: The Gruesome
Analyst consensus upside (%): 70.79738562091502
Rule of 40 score: 0
Altman Z-score: 12.22087218353918 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.020467596503305083
Total shareholder yield (%): 0.020467596503305083 (Low Return)
Momentum (%): 1m -6.23624358033748, 3m -30.04255319148935, 6m 11.265397536394183, 12m 136.75048355899426, composite 44.573214440192366 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: -0.018949494859092694
FCF conversion rate: 0.7940095142171613
Beneish M-score: -3.2234227683703436 (Likely Safe)
ROE (%): -10.575248850256843
Asset turnover: 0
Equity multiplier (leverage): 1.1495824369658774
ROE archetype: Low Return
Treasury beta 1y: -0.0027988851117178633 (R-squared: 0.00027032306922563905)
Insider 90-day net shares: -995800 (net value USD: -1179409.00)
ROIC (%): -38.99954628366695 (pretax: -49.36651428312272)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 48.300283286118976, ROIC 45.3257790368272, revenue growth 1y , 6m momentum 8.21529745042493
Sector percentiles: P/E , 6m momentum 14.214325374791784
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -27006492.70072993
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AV1.AX (Technology — Software - Infrastructure, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.04861111111111112
Market cap: 68572736 (USD: 44818781.6993464)
P/B ratio: 25.37354121867071
Debt to equity: 0.044800000000000006
Current ratio: 1.37
Interest coverage ratio: -17.7826606082717
Return on net tangible assets (%): -159.21941457804712
Buffett classification: The Gruesome
Analyst consensus upside (%): 116.75000000000001
Rule of 40 score: 47.25863868470271
Piotroski F-score: 0 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -11.892361111111107, 3m -24.382716049382715, 6m -45.4059829059829, 12m -43.536324786324776, composite -35.23460610625361 (Strong Downtrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
Equity multiplier (leverage): 2.3811775524360637
ROE archetype: Standard Business
Treasury beta 1y: 0.0024965618328370172 (R-squared: 0.00014228528294830416)
Insider 90-day net shares: -2678900 (net value USD: -147725.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 69.90950226244344, ROIC , revenue growth 1y , 6m momentum 77.60180995475113
Sector percentiles: P/E , 6m momentum 75.44210877544211
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05
Base cash flow: -4560626.797385621
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AVAH (Healthcare — Medical Care Facilities, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 9.6
Market cap: 2057786624 (USD: 2057786624)
P/E ratio: 5.322314049586777
P/B ratio: 5.824121019511425
Debt to equity: 6.239199999999999
Current ratio: 1.47
Interest coverage ratio: 2.5692902493526764
Return on net tangible assets (%): -4.602705852462844
Buffett classification: The Great
Analyst consensus upside (%): 62.267080745341595
Rule of 40 score: -2.8707130074227685
Altman Z-score: 0.4691770525650668 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 30.342863127029005, earnings yield % 2.154032152162287, rank 136
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.5934531723343538
Total shareholder yield (%): 0.5934531723343538 (Low Return)
Momentum (%): 1m 13.341204250295146, 3m 46.56488549618321, 6m 10.599078341013826, 12m 143.6548223350254, composite 57.37952770884573 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 2, short score 8, recommendation: Short
Revenue growth 1y (%): 15.859655522652826
Net income growth 1y (%): 702.0989793953399
Revenue deceleration: no
Accrual ratio: 0.02075189363941893
FCF conversion rate: -0.004993637913235541
Beneish M-score: -2.257444240825413 (Likely Safe)
ROE (%): 19.10806403148819
Net margin (%): 6.428775379486506
Asset turnover: 0.32119307153159543
Equity multiplier (leverage): 9.253845995050153
ROE archetype: Leverage-Driven Returns
P/E z-score: 1.8505133233870759
FCF z-score: 4.373427466769674
Treasury beta 1y: 0.001258424320902161 (R-squared: 6.704921729643387e-05)
Insider 90-day net shares: -31305664 (net value USD: -215555698.00)
ROIC (%): 13.559259845427448 (pretax: 17.1636200575031)
Incremental ROIC 3y (%): 403.2965360667161 (pretax: 510.5019443882482)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 39.523809523809526, P/B 60.476190476190474, ROIC 19.047619047619047, revenue growth 1y 17.61904761904762, 6m momentum 26.666666666666668
Sector percentiles: P/E 17.80085959885387, 6m momentum 19.806590257879655
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.11368095258253541
Base cash flow: 245812000
DCF price per share: base 17.345131114121592, conservative 9.473735808942337, aggressive 29.634924313953864
Financial scorecard for AYA.AX (Healthcare — Health Information Services, Australia)
Report date: 2025-06-30 (annual)
Stock price: 3.9166666666666665
Market cap: 922559872 (USD: 602980308.496732)
P/B ratio: 5.532134086147775
Debt to equity: 0.0051
Current ratio: 37.11
Return on net tangible assets (%): -95.54855837500773
Buffett classification: The Gruesome
Analyst consensus upside (%): 1204.75
Rule of 40 score: -51907.14285714287
Piotroski F-score: 0 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.1391779589563592
Debt paydown yield (%): 0.037285384985832115
Total shareholder yield (%): 0.17646334394219132 (Low Return)
Momentum (%): 1m 6.5509693558474, 3m 34.725634725634706, 6m 35.50552922590837, 12m 479.8202614379085, composite 171.46763387070817 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 4, short score 12, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.08693180868315024
FCF conversion rate: 0.8858954041204438
Beneish M-score: -2.53163901338792 (Likely Safe)
ROE (%): -85.3832566379419
Net margin (%): -58592.857142857145
Asset turnover: 0.0013002620956881449
Equity multiplier (leverage): 1.120720038054515
ROE archetype: Low Return
Treasury beta 1y: 0.006118038296515709 (R-squared: 0.0008237719193663031)
Insider 90-day net shares: -300000 (net value USD: -972600.00)
ROIC (%): -167.2237346625767 (pretax: -211.6756134969325)
Incremental ROIC 3y (%): -95.19855763837525 (pretax: -120.50450333971543)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 46.8421052631579, ROIC 57.89473684210527, revenue growth 1y , 6m momentum 6.315789473684211
Sector percentiles: P/E , 6m momentum 8.989971346704872
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0815373184186141
Base cash flow: -10115032.679738563
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for AYT.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0
Market cap: 6576574 (USD: 4384382.666666667)
P/B ratio: 0
Debt to equity: 0
Current ratio: 12.89
Return on net tangible assets (%): -9.858266718348448
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 1.6797651786477272
Total shareholder yield (%): 1.6797651786477272 (Low Return)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.03875078552140634
FCF conversion rate: 1.817963074548249
Beneish M-score: -2.3497858728758163 (Likely Safe)
ROE (%): -4.790856249654044
Equity multiplier (leverage): 1.011268147202064
ROE archetype: Low Return
Treasury beta 1y: 2.2297781266417287 (R-squared: 0.0003704455744876797)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -4.025770679087694 (pretax: -5.0959122520097395)
Incremental ROIC 3y (%): 4.2470979338067965 (pretax: 5.376073333932653)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 60.69941715237302, ROIC 13.238967527060783, revenue growth 1y , 6m momentum 
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1129
Base cash flow: -1061753.3333333333
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BATRA (Communication Services — Entertainment, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 55.04
Market cap: 3530476032 (USD: 3530476032)
P/B ratio: 0.9159384075556526
Debt to equity: 1.5383000000000002
Current ratio: 0.46
Interest coverage ratio: -3.693017009847807
Return on net tangible assets (%): -14.54689585734657
Buffett classification: The Gruesome
Rule of 40 score: 83.12525871170352
Altman Z-score: 1.0659857385085776 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 2.5522940518206076, earnings yield % 0.3930385511754032, rank 5417
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.7977677725245637
Total shareholder yield (%): 0.7977677725245637 (Low Return)
Momentum (%): 1m -1.9943019943019897, 3m 2.5717480432351896, 6m 28.8691173027394, 12m 10.499899618550485, composite 14.729769811169069 (Moderate Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue growth 1y (%): 52.52165808815743
Revenue deceleration: no
Accrual ratio: -0.05709928463124577
FCF conversion rate: -1.3320882600306734
Beneish M-score: -1.7042736550431494 (Possible Manipulation)
ROE (%): -7.5609678547581955
Net margin (%): -56.14176399516714
Asset turnover: 0.043611360018266536
Equity multiplier (leverage): 3.0881025011829792
ROE archetype: Low Return
Treasury beta 1y: 0.004923186415708692 (R-squared: 0.013845444820733584)
Insider 90-day net shares: 34500 (net value USD: 1523950.00)
ROIC (%): 1.028397602499422 (pretax: 1.3017691170878758)
Incremental ROIC 3y (%): 6.909188774837004 (pretax: 8.745808575743041)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 21.69811320754717, ROIC 41.0377358490566, revenue growth 1y 5.188679245283019, 6m momentum 11.79245283018868
Sector percentiles: P/E , 6m momentum 8.380797396257119
Industry median P/E: 3.7313797891504157; industry median ROIC: 1.542068936425999
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.060002313200991475
Base cash flow: 1020000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BEAM (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 25.1
Market cap: 2582268416 (USD: 2582268416)
P/B ratio: 2.1054033530509995
Debt to equity: 0.21539999999999998
Current ratio: 16.99
Return on net tangible assets (%): -7.810205438159867
Buffett classification: The Gruesome
Analyst consensus upside (%): 119.51321863197653
Rule of 40 score: -276.0163799737893
Altman Z-score: 4.005403910759758 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -3.7447307724031735
Total shareholder yield (%): -3.7447307724031735 (Minimal or Negative)
Momentum (%): 1m -25.958702064896748, 3m -7.414238288454437, 6m -20.46894803548795, 12m 19.809069212410513, composite 11.310218719385949 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 324.8728246318608
Revenue deceleration: no
Accrual ratio: 0.024596426370918054
FCF conversion rate: 1.3862147204139188
Beneish M-score: -0.2611927089923579 (Strong Manipulation Signal)
ROE (%): -7.850687282649048
Net margin (%): -297.1768857520953
Asset turnover: 0.021430295664210536
Equity multiplier (leverage): 1.23272013104733
ROE archetype: Low Return
Treasury beta 1y: 2.4772712312892426e-05 (R-squared: 2.0559485990183052e-08)
Insider 90-day net shares: -393019 (net value USD: -13217862.00)
ROIC (%): -205.82291829348617 (pretax: -260.5353396120078)
Incremental ROIC 3y (%): -11.414538900570742 (pretax: -14.448783418443977)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 24.819494584837546, ROIC 31.498194945848372, revenue growth 1y 1.8050541516245486, 6m momentum 44.22382671480145
Sector percentiles: P/E , 6m momentum 50.71633237822349
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -72644000
DCF price per share: base 4.989984784472337, conservative 5.389613893096051, aggressive 4.544740527793429
Financial scorecard for BL (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 28.45
Market cap: 1685914752 (USD: 1685914752)
P/E ratio: 84.0909090909091
P/B ratio: 6.430574479810145
Debt to equity: 2.0364
Current ratio: 1.7
Interest coverage ratio: 3.1788291900561347
Return on net tangible assets (%): -7.098971576772399
Buffett classification: The Good
Analyst consensus upside (%): 12.027027027027035
Rule of 40 score: 6.552375687444548
Altman Z-score: 1.277375459132132 (Distress Zone)
Piotroski F-score: 9 (Strong)
Magic formula: return on capital % 2.3675848723033184, earnings yield % 0.4217613968015658, rank 2320
Dividend yield (%): 0
Buyback yield (%): 3.4256180469082222
Debt paydown yield (%): 13.82549145640313
Total shareholder yield (%): 17.25110950331135 (High Return)
Momentum (%): 1m 5.253422123566401, 3m -7.147519582245435, 6m -46.4016578749058, 12m -49.6549283312688, composite -35.23897845870121 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 4, short score 10, recommendation: Neutral
Revenue growth 1y (%): 9.718985688697735
Net income growth 1y (%): 34.20313790255987
Revenue deceleration: no
Accrual ratio: -0.017195447517400268
FCF conversion rate: 4.401673640167364
Beneish M-score: -2.720387394878929 (Likely Safe)
ROE (%): 2.2923460579320927
Net margin (%): 4.436679315334007
Asset turnover: 0.11393648035776882
Equity multiplier (leverage): 4.534812572640797
ROE archetype: Low Return
P/E z-score: 3.761799679759776
FCF z-score: 4.4787568942818385
Treasury beta 1y: 0.020092411322110627 (R-squared: 0.03318876204412001)
Insider 90-day net shares: -5876 (net value USD: -172957.00)
ROIC (%): 5.084416772771697 (pretax: 7.822179650417996)
Incremental ROIC 3y (%): 130.73279085537152 (pretax: 179.27927927927928)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 53.09973045822103, P/B 59.703504043126685, ROIC 41.64420485175202, revenue growth 1y 31.805929919137466, 6m momentum 81.40161725067385
Sector percentiles: P/E 51.45145145145145, 6m momentum 75.9426092759426
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.06639286907999548
Base cash flow: 65718000
DCF price per share: base 49.71594964778077, conservative 29.264856329383978, aggressive 84.77693618624393
Financial scorecard for BLBD (Industrials — Farm & Heavy Construction Machinery, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 76.2
Market cap: 2411469824 (USD: 2411469824)
P/E ratio: 14.16209476309227
P/B ratio: 6.032362816888645
Debt to equity: 0.2953
Current ratio: 1.84
Interest coverage ratio: 25.319093851132685
Return on net tangible assets (%): 10.704291533985307
Buffett classification: The Great
Analyst consensus upside (%): 48.793801725655925
Rule of 40 score: 16.71263011193728
Altman Z-score: 5.025233846774244 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 11.848446023510311, earnings yield % 1.7592515892070923, rank 361
Dividend yield (%): 0
Buyback yield (%): 0.2150970312121144
Debt paydown yield (%): 0.04860106431089224
Total shareholder yield (%): 0.26369809552300666 (Low Return)
Momentum (%): 1m 1.1012339126973574, 3m 17.2127365020766, 6m 53.722009279806336, 12m 68.02646085997796, composite 45.71033238668425 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 9, short score 0, recommendation: Long
Revenue growth 1y (%): -1.7321952565270804
Net income growth 1y (%): 12.49712047915228
Revenue deceleration: no
Accrual ratio: -0.01592844066182776
FCF conversion rate: 1.3619671683560288
Beneish M-score: -2.322664997701261 (Likely Safe)
ROE (%): 10.293766335965824
Net margin (%): 8.309158194733932
Asset turnover: 0.5295988754274592
Equity multiplier (leverage): 2.3392154520671147
ROE archetype: Standard Business
P/E z-score: 4.033921357233412
FCF z-score: 4.033921357233414
Treasury beta 1y: -0.006063831043743356 (R-squared: 0.0036816998512449566)
Insider 90-day net shares: -8817 (net value USD: -523759.00)
ROIC (%): 106.38620944168117 (pretax: 143.58133063061516)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 51, P/B 71, ROIC 0, revenue growth 1y 45, 6m momentum 3
Sector percentiles: P/E 50.25601638504864, 6m momentum 5.529953917050691
Industry median P/E: 1.1720622195111323; industry median ROIC: 7.227589214896717
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.11769310814730417
Base cash flow: 120434000
DCF price per share: base 105.0106761147754, conservative 64.25219221584365, aggressive 175.2827403133553
Financial scorecard for BLCO.TO (Healthcare — Medical Instruments & Supplies, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 16.113475177304963
Market cap: 8100505600 (USD: 5827701870.503597)
P/B ratio: 1.2195842252107878
Debt to equity: 0.7857999999999999
Current ratio: 1.53
Interest coverage ratio: 0.6082474226804123
Buffett classification: The Gruesome
Analyst consensus upside (%): 18.719981875849566
Rule of 40 score: -82.17302026651674
Altman Z-score: 0.7491073178646351 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 2.1454545454545455, earnings yield % 0.32712436611173673, rank 2423
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.0640049557140878
Total shareholder yield (%): 1.0640049557140878 (Low Return)
Momentum (%): 1m 2.744206339349111, 3m 1.8240820706079341, 6m -4.358727979867326, 12m 15.096251266464037, composite 3.1624956291737703 (Moderate Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 6, recommendation: Neutral
Revenue growth 1y (%): 12.559240206779165
Revenue deceleration: no
Accrual ratio: -0.0001428229636390456
FCF conversion rate: 0.9714285714285714
Beneish M-score: -1.1079359583275439 (Strong Manipulation Signal)
ROE (%): -1.071469471778958
Net margin (%): -5.627009646302251
Asset turnover: 0.08883588338348646
Equity multiplier (leverage): 2.1434517740975885
ROE archetype: Low Return
Treasury beta 1y: 0.006181108513288071 (R-squared: 0.006081646160822629)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 1.3239436619718312 (pretax: 1.6758780531289)
Incremental ROIC 3y (%): 0.22711967022576782 (pretax: -1.7086670378993691)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 19.018404907975462, ROIC 59.50920245398773, revenue growth 1y 22.699386503067483, 6m momentum 42.331288343558285
Sector percentiles: P/E , 6m momentum 34.419770773638966
Industry median P/E: 15.690276110444179; industry median ROIC: 5.717819487534456
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07393364775236842
Base cash flow: -204379562.04379562
DCF price per share: base 0, conservative 0, aggressive 0